<code id='CF9A464D65'></code><style id='CF9A464D65'></style>
    • <acronym id='CF9A464D65'></acronym>
      <center id='CF9A464D65'><center id='CF9A464D65'><tfoot id='CF9A464D65'></tfoot></center><abbr id='CF9A464D65'><dir id='CF9A464D65'><tfoot id='CF9A464D65'></tfoot><noframes id='CF9A464D65'>

    • <optgroup id='CF9A464D65'><strike id='CF9A464D65'><sup id='CF9A464D65'></sup></strike><code id='CF9A464D65'></code></optgroup>
        1. <b id='CF9A464D65'><label id='CF9A464D65'><select id='CF9A464D65'><dt id='CF9A464D65'><span id='CF9A464D65'></span></dt></select></label></b><u id='CF9A464D65'></u>
          <i id='CF9A464D65'><strike id='CF9A464D65'><tt id='CF9A464D65'><pre id='CF9A464D65'></pre></tt></strike></i>

          Home / Wikipedia / knowledge

          knowledge


          knowledge

          author:fashion    Page View:45
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In